CERT certara.com: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Corporate company logo of certara.com (CERT)

Certara, Inc. (CERT) generates revenue through B2B subscriptions, providing pharmaceutical giants with software for virtual drug modeling. The company's current EV/EBITDA level captures the business valuation relative to earnings, where 22.25 indicates the value of this metric. A cloud-based architecture without physical assets ensures service stability. An impeccable image and the trust of the FDA transform the company into an indispensable intellectual monopolist.

CERT (Certara Inc) Enterprise Value to Operating Income Before Depreciation Ratio history from 11/23/2025 to 11/10/2026
Original product of certara.com

Professional selection of resilient assets is based on identifying business undervaluation relative to its EBITDA. By analyzing the EV/EBITDA trend over time, an investor assesses capital management efficiency, which for Certara, Inc. (CERT) is confirmed by exceptional revenue stability driven by the integration of biosimulation software into the critical R&D processes of pharma behemoths and support from the FDA.

Key competitors

EV/EBITDA Multiple VEEV (Veeva Systems Inc)|Doximity Network (DOCS) - Company Value to EBITDA|HQY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation WAY (waystar.com)|CRVL (CorVel) - Enterprise Value to EBITDA Ratio|PRVA: Enterprise Value to Operating Income Before Depreciation Ratio|HURN (Huron Consulting) - EV/EBITDA Multiple|EV/EBITDA Multiple Omnicell Health|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization GoodRx Holdings, Inc. (GDRX)|SDGR (schrodinger.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple PHR (Phreesia)|EV/EBITDA Multiple Omada Health, Inc. OMDA|EVH: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation HSTM (HealthStream Learning)|DH: EV/EBITDA Multiple|CCSI - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization agilon health|Enterprise Value to Operating Income Before Depreciation ABSI (Absci Corp)|EV/EBITDA Multiple SY|Enterprise Value to EBITDA Ratio National Research Corp. NRC|Spok Holdings, Inc. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio optimizerx.com (OPRX)|TruBridge - EV/EBITDA Multiple|Simulations Plus Inc (SLP) - Enterprise Value to EBITDA Ratio|SOPH: EV/EBITDA Multiple|Company Value to EBITDA Health Catalyst Inc (HCAT)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareCloud Inc.|RSSS: Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio DLHC (DLH Holdings Corp.)|Enterprise Value to Operating Income Before Depreciation Ratio ONMD|EV/EBITDA Multiple SCNX (Scienture Holdings Inc.)|Total Company Value to Operating Income Before Depreciation Ratio Healthcare Triangle Corporation (HCTI)|ISPC: Enterprise Value to EBITDA Ratio|Bullfrog AI Holdings - Enterprise Value to Operating Income Before Depreciation Ratio|WORX (SCWorx) - Enterprise Value to EBITDA Ratio|MSP Recovery Inc. - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization iCoreConnect, Inc.|Enterprise Value to EBITDA Ratio TRxADE Health Corp (MEDS)|EV/EBITDA Multiple ORGS|RCM - Company Value to EBITDA|EV/EBITDA Multiple SHCR (Sharecare)|STRM: Enterprise Value to Operating Income Before Depreciation|Syra Health Corporation - EV/EBITDA Multiple|Apollo Medical Holdings (AMEH) - Enterprise Value to EBITDA Ratio|MODN: EV/EBITDA Multiple|Company Value to EBITDA nextgen.com (NXGN)